5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid, 7-[[(2R)-2-amino-2-(1,4-cyclohexadien-1-yl)acetyl]amino]-3-methyl-8-oxo-,(6R,7R)- cas no:38821-53-3
Synonyms: 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid, 7-[(amino-1,4-cyclohexadien-1-ylacetyl)amino]-3-methyl-8-oxo-, [6R-[6a,7b(R*)]]-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2R)-amino-1,4-cyclohexadien-1-ylacetyl]amino]-3-methyl-8-oxo-, (6R,7R)-(9CI);7-[D-a-Amino-(1,4-cyclohexadienyl)acetamide]-3-desacetoxycephalosphoranicacid;Anspor;Cefradex;Cefradin;Cefradine;Cefrag;Cefro;Celex;Cephradin;Cephradine;Cesporan;Dimacef;Easkacef;Ecosporina;Eskacef;Lenzacef;Lisacef;Megacef;SQ 11436;Samedrin;Sefril;Velocef;Velosef;
Name5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid, 7-[[(2R)-2-amino-2-(1,4-cyclohexadien-1-yl)acetyl]amino]-3-methyl-8-oxo-,(6R,7R)-
CAS38821-53-3
Synonyms5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid, 7-[(amino-1,4-cyclohexadien-1-ylacetyl)amino]-3-methyl-8-oxo-, [6R-[6a,7b(R*)]]-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2R)-amino-1,4-cyclohexadien-1-ylacetyl]amino]-3-methyl-8-oxo-, (6R,7R)-(9CI);7-[D-a-Amino-(1,4-cyclohexadienyl)acetamide]-3-desacetoxycephalosphoranicacid;Anspor;Cefradex;Cefradin;Cefradine;Cefrag;Cefro;Celex;Cephradin;Cephradine;Cesporan;Dimacef;Easkacef;Ecosporina;Eskacef;Lenzacef;Lisacef;Megacef;SQ 11436;Samedrin;Sefril;Velocef;Velosef;
EINECS(EC#)254-137-8
Molecular FormulaC16H19N3O4S
Molecular Weight349.4
AppearanceSolid
refractive index1.684
storage tempStore at 0-5°C
Hazard Xi:Irritant
Risk R36/37/38;R42/43
Safety
Moderately toxic by ingestion, intraperitoneal, subcutaneous, and intravenous routes. Human systemic effects: dermatitis. An experimental teratogen. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of SOx and NOx.
The Hazard Codes of Sefril (CAS NO.38821-53-3):
Xi,
Xn
The Risk Statements information of SEFRIL(38821-53-3): 20/21/22-36/37/38-42/43
R20/21/22:Harmful by inhalation, in contact with skin and if swallowed.?
R36/37/38:Irritating to eyes, respiratory system and skin.?
R42/43:May cause sensitization by inhalation and skin contact.
The Safety Statements information of Sefril (CAS NO.38821-53-3): 26-36
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.?
S36:Wear suitable protective clothing.?
RTECS XI0336000
| 1. |
??? |
orl-wmn TDLo:5?mg/kg:SKN
|
??? |
CUTIBC ?? CUTIS; Cutaneous Medicine for the Practitioner. 38 (1986),58. |
| 2. |
??? |
orl-mus LD50:3549?mg/kg
|
??? |
NKRZAZ ?? Chemotherapy (Tokyo). 23 (1975),37. |
| 3. |
??? |
ipr-mus LD50:597?mg/kg
|
??? |
IYKEDH ?? Iyakuhin Kenkyu. Study of Medical Supplies. 8 (1977),680. |
| 4. |
??? |
scu-mus LD50:2890?mg/kg
|
??? |
IYKEDH ?? Iyakuhin Kenkyu. Study of Medical Supplies. 8 (1977),680. |
| 5. |
??? |
ivn-mus LD50:3539?mg/kg
|
??? |
IYKEDH ?? Iyakuhin Kenkyu. Study of Medical Supplies. 8 (1977),680. |
